Thyroxine sulfate (T4S) is an endogenous metabolite of the thyroid hormone thyroxine (T4); it serves as a biomarker for altered thyroid hormone metabolism, particularly under conditions of reduced type I 5'-monodeiodinase (D1) activity, such as in fetal development, critical illness, or drug-induced inhibition (e.g., by ipodate); elevated levels of T4S in serum, amniotic fluid, meconium, bile, and allantoic fluid reflect impaired deiodination and enhanced sulfation of thyroxine; it is used in research to study thyroid hormone metabolism, fetal thyroid function, and the impact of deiodinase inhibition on hormone clearance.